Focused Wealth Management, Inc Crispr Therapeutics Ag Transaction History

Focused Wealth Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$39.19 - $65.67 $31,352 - $52,536	-800 Reduced 88.89%	100 $0
Q3 2022 Oct 20, 2022	BUY	$61.1 - $83.78 $48,880 - $67,024	800 Added 800.0%	900 $59,000
Q4 2020 Feb 03, 2021	SELL	$79.67 - $173.23 $3,983 - $8,661	-50 Reduced 33.33%	100 $15,000
Q3 2020 Oct 19, 2020	SELL	$78.5 - $100.64 $3,925 - $5,032	-50 Reduced 25.0%	150 $13,000
Q1 2018 May 07, 2018	BUY	$23.52 - $58.17 $4,704 - $11,634	200 New	200 $9,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.